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A 90 year-old male patient, known to have severe aortic stenosis (AS), was admitted with chest pain, shortness of
breath and swelling of both lower limbs. He had history of ischemic heart disease and percutaneous coronary
intervention (PCI) of left anterior descending artery (LAD) in 2002. He also had long standing hypertension, primary
hypothyroidism and hypercalcemia. He had a permanent pacemaker, chronic gastritis, gastrointestinal bleeding and
bilateral knee osteoarthritis in 2007. Patient was treated medically for his heart failure symptoms. Transthoracic
echocardiogram (TTE) showed normal ejection fraction >55% and severe aortic stenosis, aortic valve area 0.58 cm2, mean
G 64 mmHg and peak gradient of 118 mm Hg. In November 2010 the patient was evaluated for the transcatheter aortic
valve implantation (TAVI) program after a multidisciplinary evaluation. His predicted Euro Score was 28% and both
risk and benefits were explained to the family. A 29 mm core valve prosthesis was deployed. The TTE 4 days later
showed mitral valve (MV) area = 2.04 cm2 and MG across MV = 6 mm Hg. Impingement of anterior mitral valve leaflet
(AMVL) by the inflow portion of core valve prosthesis led to mild mitral stenosis (MS). TEE is a helpful tool to
diagnose this phenomenon.
 2012 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.Discussion
Degenerative aortic stenosis (AS) is common inelderly patients. Due to significant comor-
bidities, they are often at high operative risk;
therefore, transcatheter aortic valve implantation
(TAVI) is becoming an alternative treatment.
TAVI procedures are associated with major vascu-
lar complications (11.5%), life-threatening bleed-
ing (8.5%), and acute kidney injury (6.2%).
However, new left bundle branch block (20.0%)
or permanent pacemaker implantation (34.7%)
were more frequent in patients treated with a1016–7315  2012 King Saud University.
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doi:10.1016/j.jsha.2012.02.007medtronic core valve prosthesis [1]. TAVI is asso-
ciated with a high rate of silent cerebral ischemic
lesions as evaluated by DW-MRI, with no differ-
ence between the transfemoral (TF) and transapi-
cal (TA) approaches [2]. Consequently, the
European Association of Echocardiography in
partnership with the American Society of Echocar-
diography has developed recommendations for
the use of echocardiography in new transcatheter
interventions for valvular heart disease [3]. Mitral
stenosis has not been reported as a post-TAVI
complication (Figs. 1–4).
Figure 4. 3D TEE showing the struts of the core valve at LVOT with
pushing the AMVL.
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Figure 1. Aortogram showed a lower deployment of core valve by
10 mm from the base of aortic root.
Figure 2. 2D TEE view of the mitral valve showing fully opening of
both leaflets with no restriction at the hinge point of the anterior
mitral leaflet (AMVL).
Figure 3. 2D TEE view of the mitral valve, post TAVI showing
restricted anterior mitral leaflet (AMVL) due to the strut of the core
valve in LVOT.
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